Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Schwehm

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Pharmacoeconomics|September 21, 2016
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission ModelChristiaan Dolk, Martin Eichner, Robert Welte, et al.
BMC Infectious Diseases|January 24, 2014
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation studyMarkus A Rose, Oliver Damm, Wolfgang Greiner, et al.
Human Vaccines & Immunotherapeutics|April 29, 2022
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in GermanyDaniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?Andreia Vasconcelos, Jonathan D King, Cláudio Nunes-Alves, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Pharmacoeconomics|September 21, 2016
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission ModelChristiaan Dolk, Martin Eichner, Robert Welte, et al.
BMC Infectious Diseases|January 24, 2014
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation studyMarkus A Rose, Oliver Damm, Wolfgang Greiner, et al.
Human Vaccines & Immunotherapeutics|April 29, 2022
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in GermanyDaniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?Andreia Vasconcelos, Jonathan D King, Cláudio Nunes-Alves, et al.
Pageof 3